Geron Group has been on a explosive move forward in 2019 and like many Pharmaceutical companies it is moving on very little publicly released news. We have a alert on the stock for a break of $2.40 where it meets resistance and the 200ma with a major gap above.
GERN dropped very badly in premarket today because of some bad news involving Johnson & Johnson's (NYSE:JNJ) Janssen unit. I was curious to see if there was any insider trading in the days before the news was released. I found out there were two transactions, both of the director and the secretary sold a total of $7 million dollars in late August - middle...
This stock has been in our watchlist for a few weeks now. From the last pullback we had last week and a tested level on the demand zone, we are now more convince with this as one with potential growth.
With JNJ as a backing, let's hope this happen.
Possible Double Bottom at $5.10
Stock looks like its ready to run and run fast
If $5.10 can represent the low going forward, we break above multi-year resistance of $6.50 and hold;
might get a double here!
Time will tell.
... for a 3.22 debit.
Max Profit: $78/contract
Max Loss/Buying Power Effect: $322 per contract
Break Even/Cost Basis: 3.22/share
Notes: A speculative shot on a high implied volatility biotech underlying ... .
i got a Sales Pitch call "Belford Style" which resembled basically the Wolf of Wallstreet Sales and the "Boileroom Closer" in a single phone conversation.
the call happend while i was trading the markets live, and happend to record a few bits out of it.
here is a small cutout of it on Youtube: youtu.be
so this Idea serves as a reminder of...
Market retreats to 20 period EMA after making new highs (for long positions)/lows (for shorts) with ADX (14period) >30. Some people use the 20 period SMA. Projection is a retest of the highs. Trailing stop. Failed grails tend to move (painfully) in the opposite direction.